12:00 AM
 | 
Jul 19, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Florbetapir: Additional Phase III data

Avid Radiopharmaceuticals Inc., Philadelphia, Pa.
Product: Florbetapir ( 18F-AV-45) (formerly Florpiramine)
Business: Diagnostic
Molecular target: Beta amyloid
Description: Imaging agent labeled with fluorine 18 (F-18) that binds to amyloid plaques
Indication: Diagnose Alzheimer's disease
Endpoint: Correlation between beta amyloid levels in positron emission...

Read the full 209 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >